Serious adverse events and the modafinil augmentation study.
Block
Jerald
J
D001559:Benzhydryl Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D000077408:Modafinil; D009503:Neutropenia / Q000139:chemically induced; D017367:Selective Serotonin Reuptake Inhibitors / Q000378:metabolism / Q000627:therapeutic use; D020280:Sertraline / Q000378:metabolism / Q000627:therapeutic use; D013405:Suicide / Q000523:psychology
D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D000077408:Modafinil; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline